lamictal tuggu-/dreifitafla 200 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 200 mg
lamictal tuggu-/dreifitafla 2 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 2 mg
lamictal tuggu-/dreifitafla 100 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 100 mg
competact
cheplapharm arzneimittel gmbh - lyfleysu, kvarta stutt og long-term - sykursýki, tegund 2 - lyf notuð við sykursýki - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
mydrane stungulyf, lausn 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml
laboratoires thea* - lidocainum hýdróklóríð; phenylephrinum hýdróklóríð; tropicamidum inn - stungulyf, lausn - 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml
duokopt (joz) augndropar, lausn 20 mg/ml + 5 mg/ml
laboratoires thea s.a.s. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml + 5 mg/ml
seroxat filmuhúðuð tafla 20 mg
glaxosmithkline pharma a/s - paroxetinum hýdróklóríð - filmuhúðuð tafla - 20 mg
calcium sandoz freyðitafla 500 mg
sandoz a/s - calcii carbonas; calcii lacto-gluconas - freyðitafla - 500 mg
valtrex filmuhúðuð tafla 250 mg
glaxosmithkline pharma a/s - valaciclovirum hýdróklóríð - filmuhúðuð tafla - 250 mg